4.7 Article

Search and Contain: Impact of an Integrated Genomic and Epidemiological Surveillance and Response Program for Control of Carbapenemase-producing Enterobacterales

Related references

Note: Only part of the references are listed.
Review Public, Environmental & Occupational Health

Health outcomes attributable to carbapenemase-producing Enterobacteriaceae infections: A systematic review and meta-analysis

Dalton R. Budhram et al.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2020)

Article Public, Environmental & Occupational Health

Carbapenemase-producing Enterobacteriaceae in Australian hospitals: outcome of point-prevalence screening in high-risk wards

J. A. Brett et al.

JOURNAL OF HOSPITAL INFECTION (2019)

Article Public, Environmental & Occupational Health

Israeli National Policy for Carbapenem-Resistant Enterobacteriaceae Screening, Carrier Isolation and Discontinuation of Isolation

Ester Solter et al.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2018)

Review Public, Environmental & Occupational Health

Control of carbapenemase-producing Enterobacteriaceae outbreaks in acute settings: an evidence review

C. E. French et al.

JOURNAL OF HOSPITAL INFECTION (2017)

Article Infectious Diseases

Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States

S. M. Bartsch et al.

CLINICAL MICROBIOLOGY AND INFECTION (2017)

Article Microbiology

Dominance of IMP-4-Producing Enterobacter cloacae among Carbapenemase-Producing Enterobacteriaceae in Australia

Hanna E. Sidjabat et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)

Article Immunology

An Ongoing National Intervention to Contain the Spread of Carbapenem-Resistant Enterobacteriaceae

Mitchell J. Schwaber et al.

CLINICAL INFECTIOUS DISEASES (2014)

Article Immunology

Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae Infections

Matthew E. Falagas et al.

EMERGING INFECTIOUS DISEASES (2014)